author-photo

Piotr Jagiello

Novartis

7

Papers

20

Citations

Citation Trend

Filter By

Papers (4) Sort By

Journal Conference Others

Tolérance et maintien sous traitement par sécukinumab chez des patients atteints de rhumatisme psoriasique ou de spondyloarthrite ankylosante : résultats intermédiaires à 2 ans de l’étude observationnelle SERENA

2021 Revue du Rhumatisme
Show All
- Source
- Cite
- Save
Citations (0)
Secukinumab effects on disease burden, patient needs and benefits, and treatment satisfaction in patients with plaque psoriasis across European regions: Patient perspective data from the PROSE study

2021 Journal of The European Academy of Dermatology and Venereology
Show All
- Source
- Cite
- Save
Citations (0)
Secukinumab Use in Patients with Moderate to Severe Psoriasis, Psoriatic Arthritis and Ankylosing Spondylitis in Real-World Setting in Europe: Baseline Data from SERENA Study.

2020 Advances in Therapy
Show All
- Source
- Cite
- Save
Citations (10)
Efficacy and safety of secukinumab in moderate to severe palmoplantar pustular psoriasis over 148 weeks: extension of the 2PRECISE study.

2020 Journal of The American Academy of Dermatology
Show All
- Source
- Cite
- Save
Citations (2)